Difference between revisions of "Andrew Philip Witty"
Jump to navigation
Jump to search
| Line 30: | Line 30: | ||
}}'''Sir Andrew Philip Witty''' is a [[big pharma]] executive involved in organising the [[response to COVID-19]]. | }}'''Sir Andrew Philip Witty''' is a [[big pharma]] executive involved in organising the [[response to COVID-19]]. | ||
| + | |||
| + | ==Activities== | ||
In April 2020, Witty began a leave of absence from Optum to assist the [[WHO]] in developing a [[vaccination for COVID-19]]. | In April 2020, Witty began a leave of absence from Optum to assist the [[WHO]] in developing a [[vaccination for COVID-19]]. | ||
| + | |||
| + | ==Statements== | ||
| + | * In 2013 he reported he was "absolutely committed to rooting out corruption".<ref>https://www.theguardian.com/business/2013/jul/24/gsk-china-crisis-ceo-andrew-witty-live</ref> | ||
==Awards== | ==Awards== | ||
Revision as of 15:31, 17 April 2020
 Andrew Philip Witty    (businessman) | |
|---|---|
 At Chatham House in 2015 | |
| Born | August 1964 |
| Residence | UK |
| Nationality | UK |
Sir Andrew Philip Witty is a big pharma executive involved in organising the response to COVID-19.
Contents
Activities
In April 2020, Witty began a leave of absence from Optum to assist the WHO in developing a vaccination for COVID-19.
Statements
- In 2013 he reported he was "absolutely committed to rooting out corruption".[1]
Awards
Witty was knighted in the 2012 New Year Honours for services to the economy and the UK pharmaceutical industry.
Many thanks to our Patrons who cover ~2/3 of our hosting bill. Please join them if you can.
